Macular Degeneration, Age Related
7
0
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
1 terminated out of 7 trials
80.0%
-6.5% vs benchmark
14%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy
Effect of Minimizing Light Exposure Intensity on Macular Function After Cataract Surgery in Patients With Early or Intermediate AMD
Evaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry Age-Related Macular Degeneration Patients
VISUPRIME® Eye Drops
Clinical Evaluation of VeriSee AMD in Screening for Age-Related Macular Degeneration
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy